Vendors
日本語

CRD IV Large exposures solution

Create a vendor selection project
Click to express your interest in this report
Indication of coverage against your requirements
A subscription is required to activate this feature. Contact us for more info.
Celent have reviewed this profile and believe it to be accurate.
We are waiting for the vendor to publish their solution profile. Contact us or request the RFX.
Projects allow you to export Registered Vendor details and survey responses for analysis outside of Marsh CND. Please refer to the Marsh CND User Guide for detailed instructions.
Download Registered Vendor Survey responses as PDF
Contact vendor directly with specific questions (ie. pricing, capacity, etc)

Overview

AxiomSL automates the process of calculating and reporting on large exposures and concentration risk, as required by the Capital Requirements Directive IV (CRD IV). Its transparent solution gives users full access to its interpretation of the European Banking Authority’s (EBA’s) technical standards. AxiomSL’s ‘one platform’ model means the same system can be used for all other regulatory reporting and calculation requirements, greatly reducing the cost and complexity of compliance. AxiomSL provides all of the CRD IV calculations required to compute large exposures and concentration risk.

AxiomSL’s solution offers the data normalization functionality needed to combine counterparty reference data from different systems. When users upload their data to the AxiomSL platform, it is normalized, enriched and validated, and users are given the ability to make manual adjustments. The data is then used to calculate the firm’s market risk and credit risk. The results of these calculations are aggregated to identify large exposures and are used to run the CNCOM algorithms.

When the calculations have been completed, users can review the results and check whether they are as expected, based on trend analysis and the thresholds they have set. If necessary, they can adjust the input data. If a firm’s exposures exceed the limits set by the EBA, AxiomSL’s solution automatically populates the required COREP templates, using the EBA’s XBRL taxonomy. Users sign off on the reports before they are submitted to the regulator.

Users also have the option to utilize the results of the calculations to create client results cubes, which can be enriched with additional, client-specific data. These cubes give users management information (MI) about their exposures. For example, a client may wish to see all of its large exposures to banks in the UK.

AxiomSL’s solution offers unparalleled transparency. Users can drill down into all of the calculations that are used and can see how the EBA’s technical standards have been applied. Each of the standards implemented in the platform includes a reference to the corresponding article in CRD IV. This makes it easy for users to understand how AxiomSL has interpreted every article of the directive.

AxiomSL continually monitors changes to the CRD IV requirements and makes the necessary upgrades to its solution. It gives users ongoing access to earlier iterations of the EBA’s Regulatory Technical Standards (RTS), Implementing Technical Standards (ITS) and XBRL taxonomy. These are important when rerunning or resubmitting reports.

The CRD IV large exposures solution is built on the same platform as all of AxiomSL’s other offerings. This ‘one platform’ approach ensures consistency across reports submitted for different regulations. It also reduces cost and complexity because clients do not need to maintain separate systems to comply with different regulations.

Key Features

  • Calculation of exposure value
  • Large exposure identification
  • Large exposure reporting requirements
  • Limits to large exposures
  • Additional own funds requirements for large exposures in trading book
  • Large exposure exemptions
  • Exposures arising from mortgage lending

Key Benefits

  • A single platform that can be used not only for CRD IV, but also for all other reporting and calculation requirements globally
  • Automates the calculation and reporting of large exposures and concentration risk
  • Enriches and validates data
  • Enables manual adjustments
  • Drilldown into calculations, which include references to CRD IV articles
  • Sign-off functionality
  • XBRL reporting
  • MI report creation
  • Solution updated as requirements change

Product/Service details

SOLUTION OR SERVICE TYPE